- Home
- CURR vs RENB Comparison
CURR vs RENB Comparison
Compare CURR & RENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CURR
- RENB
- Stock Information
- Founded
- CURR 2013
- RENB 2011
- Country
- CURR Singapore
- RENB United States
- Employees
- CURR N/A
- RENB N/A
- Industry
- CURR Business Services
- RENB Biotechnology: Pharmaceutical Preparations
- Sector
- CURR Consumer Discretionary
- RENB Health Care
- Exchange
- CURR Nasdaq
- RENB Nasdaq
- Market Cap
- CURR 74.0M
- RENB 62.0M
- IPO Year
- CURR N/A
- RENB N/A
- Fundamental
- Price
- CURR $0.43
- RENB $0.34
- Analyst Decision
- CURR Strong Buy
- RENB
- Analyst Count
- CURR 1
- RENB 0
- Target Price
- CURR $3.50
- RENB N/A
- AVG Volume (30 Days)
- CURR 2.5M
- RENB 7.5M
- Earning Date
- CURR 08-11-2025
- RENB 05-15-2025
- Dividend Yield
- CURR N/A
- RENB N/A
- EPS Growth
- CURR N/A
- RENB N/A
- EPS
- CURR N/A
- RENB N/A
- Revenue
- CURR $43,386,858.00
- RENB N/A
- Revenue This Year
- CURR N/A
- RENB N/A
- Revenue Next Year
- CURR $21.53
- RENB N/A
- P/E Ratio
- CURR N/A
- RENB N/A
- Revenue Growth
- CURR N/A
- RENB N/A
- 52 Week Low
- CURR $0.33
- RENB $0.27
- 52 Week High
- CURR $7.08
- RENB $2.10
- Technical
- Relative Strength Index (RSI)
- CURR N/A
- RENB 49.44
- Support Level
- CURR N/A
- RENB $0.32
- Resistance Level
- CURR N/A
- RENB $0.40
- Average True Range (ATR)
- CURR 0.00
- RENB 0.06
- MACD
- CURR 0.00
- RENB 0.01
- Stochastic Oscillator
- CURR 0.00
- RENB 39.67
About CURR Currenc Group Inc. Ordinary Shares
Currenc Group Inc is a fintech banking platform for e-wallets, financial institutions and merchants world-wide, delivering frictionless interoperable real-time fund transfers and instant messaging.
About RENB Renovaro Biosciences Inc.
Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.